Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment
Phase 3
Completed
- Conditions
- Type 1 Diabetes Mellitus
- Registration Number
- NCT00213109
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Brief Summary
The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type1 Diabetes Mellitus treated with insulin.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Type1 Diabetes
- Criteria of postprandial glucose and HbA1c are met
Read More
Exclusion Criteria
- Type2 Diabetes
- Patients with antidiabetic drugs
- The other exclusion criteria are met
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method